Number of Employees: Approximately 300
Marlboro, IQOS, Chesterfield and L&M
Welcome to Philip Morris Limited, Philip Morris International's affiliate in the United Kingdom and Ireland. The history of our business in the U.K. dates back to 1847 when Mr. Philip Morris opened a tobacco shop on London's Bond Street. In doing so, he laid the foundation for what is now the leading international tobacco company in the world.
Philip Morris Limited was first incorporated in 1950 but it was not until recently that we opened affiliate offices in the U.K. and Ireland. Today, we are based in London and Dublin and are responsible for the sale and merchandising of Philip Morris International brands, including Marlboro, Chesterfield and L&M, employing approximately 300 people throughout the UK and Ireland. In June 2014, we acquired Nicocigs Ltd, a company that was formed in 2008 which has become a market leader in the UK independent sector. Nicocig is one of the market leading e-cigarette businesses in the UK and has a portfolio of brands including Nicocig, Vivid and MESH.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger unintended consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
In December 2016, the first of PMI’s revolutionary ‘Heat not Burn’ products, IQOS, was launched into the UK market. The company’s flagship IQOS store is located in Wardour Street, Central London. You can find out more about IQOS in the UK at www.iqos.co.uk .